CCM
Concord Medical Services Holdings LimitedNYSEHealthcare$3.91+0.00%ClosedMarket Cap: $569,351
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.00
P/S
0.01
EV/EBITDA
-16.51
DCF Value
$-137,711.02
FCF Yield
0.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
-8.1%
Operating Margin
-110.1%
Net Margin
-33.6%
ROE
4.2%
ROA
-1.4%
ROIC
-5.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $100.3M | -2.1% | $-72.3M | $-13.6M | $-94.50 | — |
| Q1 2025 | $100.3M | -2.1% | $-72.3M | $-13.6M | $-94.50 | — |
| Q4 2024 | $82.6M | -22.7% | $-167.2M | $-68.0M | $-468.90 | — |
| FY 2024 | $384.0M | -20.6% | $-532.2M | $-308.2M | $-2,116.80 | — |
| Q3 2024 | $82.6M | -22.7% | $-167.2M | $-68.0M | $-468.90 | — |
| Q2 2024 | $109.4M | -19.0% | $-98.9M | $-86.1M | $-591.60 | — |
| Q1 2024 | $109.4M | -19.0% | $-98.9M | $-86.1M | $-591.60 | — |
| Q4 2023 | $126.4M | -15.5% | $-338.5M | $-103.3M | $-708.00 | — |
| FY 2023 | $537.4M | -14.3% | $-463.0M | $-297.7M | $-2,044.20 | — |
| Q3 2023 | $126.4M | -15.5% | $-338.5M | $-103.3M | $-711.60 | — |
| Q2 2023 | $142.3M | -13.2% | $107.0M | $-45.5M | $-312.30 | — |
| Q1 2023 | $142.3M | -13.2% | $107.0M | $-45.5M | $-312.30 | — |